Publications by authors named "Nozomi Takada"

In regenerative medical products for clinical applications, a major concern is the risk of ruminant-derived materials developing transmissible spongiform encephalopathy (TSE) in the manufacturing process. Because of the risk of TSE causing prion disease, the raw materials derived from ruminants should be compliant with the "Standard for Biological Raw Materials" to ensure the quality and safety of pharmaceutical products. We therefore tested whether plasmid DNA could withstand four chemical reagents (Gdn-HCl, Gdn-SCN, TCA, or SDS), having referred to the report by Tateishi et al.

View Article and Find Full Text PDF

Definitive treatment of stroke constitutes an important thesis of regenerative medicine in the cerebrovascular field. However, to date, no cell therapy products for stroke are yet on the market. In this study, we examined the clinical research trends related to cell therapy products in the stroke field based on data obtained from the ClinicalTrials.

View Article and Find Full Text PDF
Article Synopsis
  • Human induced pluripotent stem cells (hiPSCs) have potential for use in cell-based therapies, but their undifferentiated state poses a risk of tumor formation post-transplantation due to intrinsic tumorigenicity.
  • A study tested the tumorigenicity of 10 hiPSC lines in a mouse model, revealing significant differences in tumor incidence, growth rate, and volume, with most resulting tumors classified as immature teratomas rather than malignant forms like carcinoma or sarcoma.
  • Investigations into the hiPSC lines showed chromosomal abnormalities and mutations in cancer-related genes; however, these factors did not lead to malignant tumors, indicating the tumorigenicity risk of therapeutic cells is influenced by both the quantity of undifferenti
View Article and Find Full Text PDF

Human pluripotent stem cells (hPSCs) are leading candidate raw materials for cell-based therapeutic products (CTPs). In the development of hPSC-derived CTPs, it is imperative to ensure that they do not form tumors after transplantation for safety reasons. Because cellular immortalization is a landmark of malignant transformation and a common feature of cancer cells, we aimed to develop an in vitro assay for detecting immortalized cells in CTPs.

View Article and Find Full Text PDF
Article Synopsis
  • The contamination of human cell-processed therapeutic products (hCTPs) with tumorigenic cells poses a significant challenge for their manufacturing and quality control, particularly due to the lack of standardized detection methods.
  • Researchers tested NOD/Shi-scid IL2Rγ (NOG) mice for their ability to detect tumorigenic cells (using HeLa cells as a model) and found that NOG mice showed a 30-fold higher sensitivity compared to traditional nude mice.
  • The study demonstrated that using Matrigel in conjunction with NOG mice further enhanced detection sensitivity by 5000 times, making this method a promising approach for rigorously assessing tumorigenic impurities in hCTPs.
View Article and Find Full Text PDF

The analysis of in vitro cell senescence/growth after serial passaging can be one of ways to show the absence of immortalized cells, which are frequently tumorigenic, in human cell-processed therapeutic products (hCTPs). However, the performance of the cell growth analysis for detection of the immortalized cellular impurities has never been evaluated. In the present study, we examined the growth rates of human mesenchymal stem cells (hMSCs, passage 5 (P = 5)) contaminated with various doses of HeLa cells, and compared with that of hMSCs alone.

View Article and Find Full Text PDF

Land plants have evolved a cuticle-bearing epidermis to protect themselves from environmental stress and pathogen attack. Despite its important role, little is known about the molecular mechanisms regulating shoot epidermal cell identity. In a recent study, we found that the Arabidopsis thaliana ATML1 gene is possibly a master regulator of shoot epidermal cell fate.

View Article and Find Full Text PDF

Molecular mechanisms that generate distinct tissue layers in plant shoots are not well understood. ATML1, an Arabidopsis homeobox gene, is expressed in the outermost cell layer, beginning at an early stage of development. The promoters of many epidermis-specific genes, including ATML1, contain an ATML1-binding site called an L1 box, suggesting that ATML1 regulates epidermal cell fate.

View Article and Find Full Text PDF

CD34+ cord blood cells can be reprogrammed effectively on dishes coated with a synthetic RGD motif polymer (PronectinF®) using a temperature sensitive Sendai virus vector (SeV TS7) carrying reprogramming factors OCT3/4, SOX2, KLF4 and c-MYC. Dish-shaped human ES cell-like colonies emerged in serum-free primate ES cell medium (supplemented with bFGF) in 20% O2 culture conditions. The copy numbers of SeV TS7 vectors in the cytoplasm were drastically reduced by a temperature shift at 38°C for three days.

View Article and Find Full Text PDF

Polarized tip growth is a fundamental cellular process in many eukaryotic organisms, mediating growth of neuronal axons and dendrites or fungal hyphae. In plants, pollen and root hairs are cellular model systems for analysing tip growth. Cell growth depends on membrane traffic.

View Article and Find Full Text PDF

After the first report of induced pluripotent stem cells (iPSCs), considerable efforts have been made to develop more efficient methods for generating iPSCs without foreign gene insertions. Here we show that Sendai virus vector, an RNA virus vector that carries no risk of integrating into the host genome, is a practical solution for the efficient generation of safer iPSCs. We improved the Sendai virus vectors by introducing temperature-sensitive mutations so that the vectors could be easily removed at nonpermissive temperatures.

View Article and Find Full Text PDF

Objective: Cord blood banks provide fully human leukocyte antigen-typed cells, from which a set of standard induced pluripotent stem (iPS) cells for use in allogenic transplantation can be derived. Hence, the ability to generate iPS cells from cord blood cells has the potential to provide a suitable source for clinical transplantation. The aim of this work is to determine the reprogramming methods, culture conditions, and cell fractions that can be used to generate iPS cells from cord blood cells effectively.

View Article and Find Full Text PDF